ENHANCING DRAVET SYNDROME OUTCOMES: STRATEGIES FOR EARLY DIAGNOSIS AND COMPREHENSIVE MANAGEMENT

Released On
November 12, 2021

Expires On
November 12, 2022

Media Type
Internet

Completion Time
60 minutes

Specialty
Neurology, Pediatrics

Topic(s)
Epilepsy

Scroll to the Bottom of this Information to Begin this Course

This activity is jointly provided by Global Education Group and PlatformQ Health Education, LLC.

In collaboration with the Dravet Syndrome Foundation and the National Organization for Rare Disorders, Inc.

This activity is supported by an educational grant from Zogenix, Inc.

Credit Available

  • Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)
  • Nurses — 1.0 Contact Hours

All other health care professionals completing this course will be issued a statement of participation.

Target Audience

The educational design of this activity addresses the needs of neurologists, pediatric neurologists, epileptologists, pediatric epileptologists, pediatricians, primary care providers, general practitioners, nurses, nurse practitioners, physician assistants, and pharmacists involved and/or interested in the management of patients with DS.

Statement of Need/Program Overview

Despite the importance of early diagnosis, Dravet syndrome (DS) is often misdiagnosed in children and is thought to be underdiagnosed in adults with epilepsy. Making a correct and early diagnosis is critical to avoiding unnecessary testing, choosing the best treatment available, and staying away from medications that can exacerbate the condition.

In addition, until recently, very little clinical evidence was available to guide the treatment of DS. Published several years ago, the guidelines do not consider the latest randomized clinical‐trial data on efficacy and safety of newer therapeutic options.

Join our esteemed panel, Dr. Danielle Andrade and Dr. Mary Zupanc, for a case-based discussion of the accurate and timely diagnosis of DS in children and adults. Once a diagnosis has been established, these experts will explore optimal treatment selections and strategies for shared decision-making with patients, families, and caregivers. Panelists will also review the importance of multidisciplinary collaborations between specialists to ensure seizures, non-seizure symptoms, side-effects, and comorbidities are addressed.

Educational Objectives

Upon completion of this activity, participants should be better able to:

  • Review data from clinical trials of new antiseizure medications as related to the standard of care of DS management
  • Evaluate each patient’s response to antiseizure medications for prompt adjustment of therapy
  • Confirm a diagnosis of DS in children presenting with symptoms or in children and adults presenting with DRE using new diagnostic approaches that include diagnostic testing
  • Devise a multidisciplinary approach to DS management to address seizure- and non‐seizure‐related symptoms

Faculty

Danielle M. Andrade, MD, MSc, FRCPC, CSCN (EEG)

Professor of Medicine (Neurology)
Medical Director, Epilepsy Program
Director of Epilepsy Genetics Research Program
Director, Epilepsy Transition Program
University of Toronto

Mary Lynn Zupanc, MD, FAAP, FAAN

Professor, Department of Pediatrics and Neurology
University of California-Irvine
CHOC-Children’s Hospital

Physician Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and PlatformQ Health Education, LLC. Global is accredited by the ACCME to provide continuing medical education for physicians.

Physician Credit Designation

Global Education Group designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

Global Education Group is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

This educational activity for 1.0 contact hour is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacist Accreditation Statement

Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.



Credit Designation

Global Education Group designates this continuing education activity for 1.0 contact hour(s) (0.10 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number - 0530-9999-21-305-H01-P)
This is a knowledge-based activity.

Disclosures of Conflicts of Interest

Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.

All relevant financial relationships have been mitigated.

The faculty have the following relevant financial relationships with ineligible companies:

Name of Faculty or Presenter Reported Financial Relationship
Danielle M. Andrade, MD, MSc, FRCPC, CSCN (EEG)
Professor of Medicine (Neurology),
Medical Director, Epilepsy Program
Director of Epilepsy Genetics Research Program
Director, Epilepsy Transition Program
University of Toronto
Consulting Fee: Stoke Therapeutic
Honoraria: Biocodex
Speakers’ Bureau: Eisai
Investigator Initiated Grant: Biocodex, Zogenix
Mary Lynn Zupanc, MD, FAAP, FAAN
Professor, Department of Pediatrics and Neurology
University of California-Irvine
CHOC-Children’s Hospital
Contracted Research: Zogenix
Speakers’ Bureau: Zogenix

 

The planners and managers have the following relevant financial relationships with ineligible companies:

Name of Planner or Manager Reported Financial Relationship
Rhys Williams, RN, MSN, FNP Nothing to disclose
Lindsay Borvansky Nothing to disclose
Andrea Funk Nothing to disclose
Liddy Knight Nothing to disclose
Ashley Cann Nothing to disclose
Kim Rodriguez Nothing to disclose
Eve Wilson Nothing to disclose
Alissa Yost Nothing to disclose

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and PlatformQ Health Education, LLC do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Instructions to Receive Credit

In order to receive credit for this activity, the participant must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credits™, participants must receive a score of 70% on the post-test. For pharmacist/ACPE learners, please check the CPE monitor for your CE credit within 60 days of the activity.

Hardware/Software Requirements

Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media

Fee Information & Refund/Canncellation Policy

There is no fee for this educational activity.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Contact Information

Accreditation Support:
For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com

Technical Support:
For any technical issues or issues with your CME Certificate, please contact NeuroSeriesLive at 877-394-1306 or at Support@NeuroSeriesLive.com.

PlatformQ Health Privacy Policy:

By clicking “Start Activity” you are agreeing to PlatformQ Health’s privacy policy. PlatformQ Health takes your privacy very seriously. The full Privacy Policy found here describes (i) the types of information we collect from you when you visit our Site; (ii) how we use the information we collect; (iii) with whom and why we share it; and (iv) the choices we offer regarding our use of the information. We also describe how to contact us about our privacy practices.

Information we collect is primarily used to communicate with program participants, award CME/CE credits, manage user accounts, recommend relevant programs and perform data analysis to inform educational outcomes.

In plain English, here is what we affirm:

  • You can change your registration profile at any time from our “Profile” page
  • To request any of these changes without logging in, please call us at 1 (877) 394-1306 or email us at support@PlatformQHealth.com
  • You can end your association with PlatformQ Health at any time
  • PlatformQ Health does not spam, nor we do we rent or sell our email list in whole or in part. Any program-related data sharing is for engagement verification and opt-in based further education
  • EU citizens can request a complete record of their account and/or request to have their personal data expunged by contacting support@PlatformQHealth.com with the subject line “Data Request”

You acknowledge and agree that by beginning this activity, you have affirmatively agreed to this Privacy Policy and consented to receiving electronic messages in conformance with this Privacy Policy. Please read the full privacy policy located at: www.platformqhealth.com/privacy-policy/